Nxera Pharma Co., Ltd.
SOLTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $192,396 | $32,997,000 | $34,465,000 | $36,203,000 |
| Short-Term Investments | $0 | $33,000 | $0 | $0 |
| Receivables | $66,431 | $6,803,000 | $4,462,000 | $6,695,000 |
| Inventory | $65,112 | $8,718,000 | $8,767,000 | $8,838,000 |
| Other Curr. Assets | $23,031 | $5,241,000 | $5,505,000 | $6,119,000 |
| Total Curr. Assets | $346,971 | $53,792,000 | $53,199,000 | $57,855,000 |
| Property Plant & Equip (Net) | $44,582 | $6,879,000 | $7,097,000 | $7,468,000 |
| Goodwill | $174,874 | $25,799,000 | $25,514,000 | $25,693,000 |
| Intangibles | $337,594 | $50,586,000 | $51,085,000 | $51,911,000 |
| Long-Term Investments | $30,359 | $3,656,000 | $3,947,000 | $4,550,000 |
| Tax Assets | $40,107 | $3,977,000 | $0 | $0 |
| Other NC Assets | $155 | $0 | $4,847,000 | $4,021,000 |
| Total NC Assets | $627,673 | $90,897,000 | $92,490,000 | $93,643,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $974,643 | $144,689,000 | $145,689,000 | $151,498,000 |
| Liabilities | – | – | – | – |
| Payables | $33,638 | $4,435,000 | $4,055,000 | $4,052,000 |
| Short-Term Debt | $45,076 | $6,676,000 | $6,682,000 | $6,690,000 |
| Tax Payable | $0 | $213,000 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $31,752 | $3,546,000 | $3,559,000 | $4,890,000 |
| Total Curr. Liab. | $110,465 | $14,870,000 | $14,296,000 | $15,632,000 |
| LT Debt | $381,751 | $58,047,000 | $59,582,000 | $61,210,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $5,509 | $986,000 | $0 | $1,857,000 |
| Other NC Liab. | $33,083 | $4,925,000 | $4,740,000 | $4,281,000 |
| Total NC Liab. | $420,344 | $63,958,000 | $64,322,000 | $67,348,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $19,347 | $3,942,000 | $4,111,000 | $4,375,000 |
| Total Liabilities | $530,809 | $78,828,000 | $78,618,000 | $82,980,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $320,762 | $47,450,000 | $47,172,000 | $47,172,000 |
| Retained Earnings | -$75,239 | -$9,458,000 | -$21,702,000 | -$20,942,000 |
| AOCI | $52,316 | $6,852,000 | $6,143,000 | $7,217,000 |
| Other Equity | $145,996 | $21,017,000 | $35,458,000 | $35,071,000 |
| Total Equity | $443,835 | $65,861,000 | $67,071,000 | $68,518,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $974,643 | $144,689,000 | $145,689,000 | $151,498,000 |
| Net Debt | $234,430 | $31,726,000 | $31,799,000 | $31,697,000 |